This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Postmenopausal Osteoporosis
and you are
over 45
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.

Provided treatments

  • Drug: Teriparatide 40-mcg subcutaneous injection
  • Drug: Denosumab Injection
  • Drug: Alendronate Oral Tablet

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01750086. The sponsor of the trial is Massachusetts General Hospital and it is looking for 27 volunteers for the current phase.
Official trial title:
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption